Highlights
- Drug interaction warnings are issued by drug compendia, which claim to be independent of drug company influence. However, this has been recently questioned and there are examples that point to drug warnings being motivated by drug company promotion.
- Clinicians should meet these warnings with skepticism and be aware of this potential.
Transcript
Hello everyone, welcome to the Psychopharmacology Institute Podcast. I'm your host, Dr. Wegdan Rashad. Today we are covering yet another interesting topic from the 2018 American Society of Clinical Psychopharmacology Annual Meeting. We met with Dr Jeffrey Mattes, who is a psychiatrist practicing in Princeton, New Jersey. He shared with us his poster entitled: Are Drug Interaction Warnings Influenced by Drug Company Promotion? This thought-provoking interview addresses some evidence that may suggest that the drug warnings
Unlock this Podcast and earn
Become a Bronze, Silver, Gold, Bronze extended, Silver extended or Gold extended Member.
Already have an account? Sign in
